Die, My Love director Lynne Ramsay was hosted by the BFI London Film Festival on Saturday and reflected on filming with A-list stars Joaquin Phoenix, Jennifer Lawrence and Robert Pattinson.
The Scot’s latest feature — following…
Blog
-
Investigational HIV bNAb N6LS shown safe, tolerable in Phase 2b trial
Researchers have posted good results showing favorable tolerability, few infusion site reactions (ISRs), and no serious drug-related adverse events (AEs) of the phase 2b trial of the investigational ultra–long-acting broadly neutralizing…
Continue Reading
-
Birth defect risk not impacted by COVID-19 vaccination
First-trimester messenger RNA (mRNA)-based COVID-19 vaccine exposure does not increase major congenital malformation (MCM) risk, according to a recent study published in JAMA Network Open.1
Data has indicated significantly increased severe…
Continue Reading
-
Full art Mythical Pokémon from Mega Evolution steadily dropping in price
Marshadow, the Gloomdweller Pokémon, is one of the rarest finds from generation VII. It’s not possible to obtain it in the digital games without downloading it via an exclusive event. In the Pokémon TCG, this shadowy lurker emerged from…
Continue Reading
-
Security, productivity, and a fresh UI — Windows 11 Home is only $15 – SFGATE
- Security, productivity, and a fresh UI — Windows 11 Home is only $15 SFGATE
- At Over 90% Off, Microsoft Windows 11 Pro Feels Like a Month-Early Black Friday Deal Kotaku
- You’re too smart to overpay — Windows 11 Pro is $10 today only Mashable
Continue Reading
-
Burnley 2-0 Leeds (Oct 18, 2025) Game Analysis
Loum Tchaouna struck a second-half stunner as Burnley beat Leeds United 2-0 in the Premier League’s battle between two newly-promoted sides at Turf Moor.
French substitute Tchaouna, a summer signing from Lazio, notched his first Burnley goal in…
Continue Reading
-
HIV updates put comorbidities first — ART on cruise control
PARIS, October 17, 2025 — The European AIDS Clinical Society (EACS) has shifted the focus of its guidelines toward managing comorbidities and the health needs of an aging HIV population, while making only incremental changes to first-line…
Continue Reading
-
For Today’s Young Content Creators, Chaos Reigns on TikTok
Polished and perfect are out, and candid and messy are in. At least that’s what it appears consumers on social media are drawn to when connecting with creators in 2025.
Some influencers are pivoting away from meticulously curated profile…
Continue Reading
-
Google Updates AI Studio with Advanced Features for Developers
Google has unveiled a series of enhancements to its AI Studio platform, aiming to empower developers with greater precision and efficiency in building artificial intelligence applications. The updates, detailed in a recent post on the
Continue Reading
-
ESMO 2025: Perioperative Enfortumab Vedotin (EV) plus Pembrolizumab (Pembro) in Participants with Muscle-Invasive Bladder Cancer (MIBC) Who Are Cisplatin-Ineligible: The Phase 3 KEYNOTE-905 Study – UroToday
- ESMO 2025: Perioperative Enfortumab Vedotin (EV) plus Pembrolizumab (Pembro) in Participants with Muscle-Invasive Bladder Cancer (MIBC) Who Are Cisplatin-Ineligible: The Phase 3 KEYNOTE-905 Study UroToday
- Pfizer and Astellas announce positive results from phase 3ev-303 clinical trial for Padcev in combination with Keytruda TradingView
- Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal The American Journal of Managed Care® (AJMC®)
- ESMO25: Padcev, Keytruda regimen given before, after surgery shines in bladder cancer FirstWord Pharma
- KEYNOTE-905: EV/pembrolizumab emerges as new option for cisplatin-ineligible MIBC Urology Times
Continue Reading